Screening for Abdominal Aortic Aneurysm in 65 Year Old Males in Oslo

Abdominal Aortic Aneurysm Clinical Trial

— AAAscreening  

Official title:

Screening for Abdominal Aortic Aneurysm

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

• NCT number: NCT01248533
• Other study ID #: 2009/866
• Status: Enrolling by invitation
• Phase: N/A
• First received: November 11, 2010
• Last updated: March 29, 2016
• Start date: May 2011
• Est. completion date: December 2029

Study information

• Verified date: March 2016
• Source: Oslo University Hospital
• Contact: n/a
• Is FDA regulated: No
• Health authority: Norway: Regional Ethics Commitee
• Study type: Observational

Clinical Trial Summary

Male subjects, 65 years of age, living in Oslo, Norway will be invited to be screened for abdominal aortic aneurysm.

Description:

The invited population will be offered ultrasound investigation of their abdominal aorta. Further information regarding risk factors will be noted and measurement of ankle-brachial index will be measured/calculated. A further step in the future will be to sample blood with focus on different cytokines and genmediators.

Recruitment information / eligibility

• Status: Enrolling by invitation
• Enrollment: 7500
• Est. completion date: December 2029
• Est. primary completion date: December 2029
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Male
• Age group: 65 Years to 65 Years

Eligibility

Inclusion Criteria:

• Males aged 65 years

Exclusion Criteria:

Study Design

Time Perspective: Prospective

Related Conditions & MeSH terms

• Abdominal Aortic Aneurysm
• Aneurysm
• Aortic Aneurysm
• Aortic Aneurysm, Abdominal

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Oslo University Hospital

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Abdominal Aortic Aneurysm (AAA)	AAA definition: diameter equal or more than 30 mm. The number of identified patients with AAA will be yearlig assessed.	Yearly the number of patients with AAA among the screened population will be assessed during the inclusion period of 18 years..	Yes
Secondary	Peripheral Arterial Disease (PAD)	Investigate the prevalence of PAD among patients with AAA defined as having Ankle-Arm Index (AAI) less than 0.9. The number of these patients will be assessed yearly.	Yearly the number of patients with PAD among the screened poplulation will be assessed during the inclusion period of 18 years.	Yes